Dr. Fadi A. Matar, MD

Dr. Matar practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Matar's NPI, 1679512479, was assigned on June 6, 2006. Dr. Matar graduated from American University of Beirut Faculty of Medicine in 1987. Dr. Matar holds Florida license ME65062.

Dr. Matar's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Matar's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. Dr. Matar is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Matar to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matar practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Matar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Matar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Matar's licenses on file in 4 states: Florida, District of Columbia, Louisiana and Maryland.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Matar treats.

CMS data shows 757 Medicare services from Dr. Matar across 13 procedure codes in 2024, for 434 Medicare patients. Medicare paid $104,605 for them.

CMS counts 434 Medicare patients who saw Dr. Matar in 2024. The largest group is 75 to 84, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matar's median patient age at 72, with 37% women.

In 2024, Dr. Matar wrote 1,354 Medicare Part D claims for 198 patients. 73% of them were for generic drugs. CMS names the drug for 1,174 of them, across 26 drugs with 11 or more claims each, at $386,122 in total drug cost. In 2023, CMS named 1,093 claims across 25 drugs.

Dr. Matar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of coronary angioplasty and stenting by Dr. Matar, more than 40% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Matar, published from 2009 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Coronary Angiography, Coronary Artery Disease and Coronary Vessels. Dr. Matar has published most often in Am J Cardiol. Dr. Matar's most frequent co-authors are Hiram G. Bezerra, MD, John T. Sullebarger, MD and Bibhu Datta Mohanty, MD.

Dmand AI links Dr. Matar to 6 clinical trials. Conditions studied include Coronary Stenosis, Coronary Artery Disease and Coronary Restenosis. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 287 general payments to Dr. Matar from 26 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Abbott Laboratories paid the most, $23,183.

Dmand AI lists 8 awards for Dr. Matar, most recently America's Top Doctors in 2014.

Dr. Matar graduated from American University of Beirut Faculty of Medicine in 1987. Dr. Matar is a member of ACC and ACP.

Dr. Matar is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.